Skip to main content
Premium Trial:

Request an Annual Quote

David Moskowitz

Biocept has appointed David Moskowitz as vice president of strategy and corporate communications. Prior to filling this newly created position at Biocept, Moskowitz was vice president of investor relations at Trovagene. He also worked as director of equity research at Caris & Co. and as head of healthcare research at Friedman Billings Ramsey. During his tenure in the financial services industry, Moskowitz held analyst positions at UBS Warburg and Roth Capital Partners, and has performed strategic advisory work for several emerging biopharmaceutical and molecular diagnostics companies. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.